Search results for "228"

showing 10 items of 834 documents

Lung Function Monitoring; A Randomized Agreement Study

2016

Objective: To determine the agreement between devices and repeatability within devices of the forced expiratory volume in 1 s (FEV1), forced vital capacity (FVC), peak expiratory flow (PEF) and forced expiratory flow at 50% of FVC (FEF50) values measured using the four spirometers included in the study. Methods: 50 (24 women) participants (20-64 years of age) completed maximum forced expiratory flow manoeuvres and measurements were performed using the following devices: MasterScreen, SensorMedics, Oxycon Pro and SpiroUSB. The order of the instruments tested was randomized and blinded for both the participants and the technicians. Re-testing was conducted on a following day within 72 hours …

Pulmonary and Respiratory Medicinemedicine.medical_specialtyVital capacitySpirometersTestingArticleMean difference03 medical and health sciencesFEV1/FVC ratio0302 clinical medicineInternal medicinemedicineAdultsRepeatability030212 general & internal medicineLung functionReproducibilitybusiness.industryMeasurementsRepeatabilityrespiratory systemReproducibilityConfidence intervalrespiratory tract diseases030228 respiratory systemPhysical therapyCardiologybusinessThe Open Respiratory Medicine Journal
researchProduct

Is an activity volume threshold really realistic for lung cancer resection?

2018

IF 1.804 (2017); International audience; Background:We analyzed volume as a continuous variable to estimate threshold, which is a methodology rarely seen in the literature. The objective of this work was to assess hospital volume for lung cancer (LC) surgery and to establish the associated threshold for acceptable in-hospital mortality (IHM). Data was obtained from the French national medico-administrative database.Methods:From January 2005 to December 2016, data from 108,571 patients operated for LC in France were collected from the national administrative database. To estimate the volume threshold, hierarchical logistic regression models were developed.Results:The crude IHM rate was 5.2% …

Pulmonary and Respiratory Medicinemedicine.medical_specialty[SDV.CAN]Life Sciences [q-bio]/Cancer030204 cardiovascular system & hematologyLung cancer (LC)Logistic regressionOddssurgery03 medical and health scienceshospital volume0302 clinical medicineHospital volumethresholdmedicineLung cancerbusiness.industryin-hospital mortality (IHM)Odds ratiomedicine.diseaseConfidence interval3. Good health030228 respiratory systemCardiothoracic surgeryEmergency medicineOriginal ArticlebusinessVolume (compression)Journal of Thoracic Disease
researchProduct

Serological biomarkers for the diagnosis of Mycobacterium abscessus infections in cystic fibrosis patients

2021

International audience; Background: Culture conditions sometimes make it difficult to detect non-tuberculous mycobacteria (NTM), particularly Mycobacterium abscessus, an emerging cystic fibrosis (CF) pathogen. The diagnosis of NTM positive cases not detected by classical culture methods might benefit from the development of a serological assay.Methods: As part of a diagnostic accuracy study, a total of 173 sera CF-patients, including 33 patients with M. abscessus positive cultures, and 31 non-CF healthy controls (HC) were evaluated. Four M. abscessus antigens were used separately, comprising two surface extracts (Interphase (INP) and a TLR2 positive extract (TLR2eF)) and two recombinant pro…

Pulmonary and Respiratory Medicinemedicine.medical_specialty[SDV]Life Sciences [q-bio]Mycobacterium Infections NontuberculousMycobacterium abscessusCystic fibrosisGastroenterologyCystic fibrosisSerology03 medical and health sciences0302 clinical medicineAntigenInternal medicineNon-tuberculous mycobacteriamedicineHumans030212 general & internal medicinePathogenComputingMilieux_MISCELLANEOUSSerodiagnosisMycobacterium abscessusbiologybusiness.industryAntibody titerNontuberculous Mycobacteriamedicine.diseasebiology.organism_classificationbacterial infections and mycoses3. Good healthMycobacterium abscessus InfectionsSerology030228 respiratory systemSerological biomarkersPediatrics Perinatology and Child HealthELISAbusinessBiomarkers
researchProduct

Should we use gait speed in COPD, FEV 1 in frailty and dyspnoea in both?

2016

Frailty is a progressive physiological decline in multiple organ systems marked by loss of function, loss of physiological reserve and increased vulnerability to disease [1]. Biological (inflammation and loss of hormones), clinical ( e.g. sarcopenia and osteoporosis) and social factors are involved in frailty onset, evolution and prognosis [2, 3]. Links between frailty, dyspnoea and chronic respiratory diseases represent a novel and practical approach

Pulmonary and Respiratory Medicinemedicine.medical_specialty[SDV]Life Sciences [q-bio]OsteoporosisDiseaseIdoso FragilizadoDispneia03 medical and health sciencesPulmonary Disease Chronic Obstructive0302 clinical medicineInternal medicineForced Expiratory VolumemedicineHumans030212 general & internal medicineLoss functionOrgan systemComputingMilieux_MISCELLANEOUSAgedAged 80 and overCOPDFrailtybusiness.industrymedicine.disease3. Good healthGait speedWalking SpeedPreferred walking speedDyspnea030228 respiratory systemSarcopeniaPhysical therapyCardiologyDoença Pulmonar Obstrutiva CrónicaVolume Expiratório ForçadoAged; Aged 80 and over; Dyspnea; Forced Expiratory Volume; Frailty; Humans; Pulmonary Disease Chronic Obstructive; Walking Speed; Pulmonary and Respiratory MedicinebusinessHuman
researchProduct

One-year follow up of asthmatic patients newly initiated on treatment with medium- or high-dose inhaled corticosteroid-long-acting β2-agonist in UK p…

2020

Abstract Introduction Global Initiative for Asthma (GINA) recommends medium- or high-dose inhaled corticosteroid-long-acting β2-agonist (ICS-LABA) as preferred treatments for patients with moderate-to-severe asthma. Limited data is available on how step 4/5 patients respond to ICS-LABA and how they step up/down in clinical practice. Methods This retrospective cohort study assessed the characteristics, control status, treatment pathways, and healthcare resource utilization in patients with asthma during one year after initiating medium- or high-dose ICS-LABA. Data from the United Kingdom Clinical Practice Research Datalink were analysed between January 01, 2006 and February 28, 2016. Results…

Pulmonary and Respiratory Medicinemedicine.medical_specialtybiologymedicine.drug_classLeukotriene receptorbusiness.industryAntagonistMuscarinic antagonistRetrospective cohort studyLamamedicine.diseasebiology.organism_classification03 medical and health sciences0302 clinical medicine030228 respiratory systemInternal medicineCohortmedicineCorticosteroid030212 general & internal medicinebusinessAsthmamedicine.drugRespiratory Medicine
researchProduct

Plexiform Vasculopathy in Chronic Thromboembolic Pulmonary Hypertension

2017

Pulmonary and Respiratory Medicinemedicine.medical_specialtybusiness.industryHypertension PulmonaryAngiographyMiddle AgedPulmonary ArteryVascular RemodelingCritical Care and Intensive Care Medicine03 medical and health sciences0302 clinical medicine030228 respiratory system030220 oncology & carcinogenesisInternal medicineChronic DiseaseMicroscopy Electron ScanningCardiologymedicineHumansFemaleChronic thromboembolic pulmonary hypertensionPulmonary EmbolismbusinessLung TransplantationAmerican Journal of Respiratory and Critical Care Medicine
researchProduct

Still puzzling about a clear definition of pulmonary arterial hypertension in newborns

2019

A more in-depth, refined definition of pulmonary arterial hypertension in newborns is neededhttp://ow.ly/DQH530nDaLz

Pulmonary and Respiratory Medicinemedicine.medical_specialtybusiness.industryMEDLINE03 medical and health sciences0302 clinical medicineText mining030228 respiratory systemInternal medicinemedicine.arteryPulmonary arterymedicineCardiologyFamilial primary pulmonary hypertension030212 general & internal medicinebusinessEuropean Respiratory Journal
researchProduct

The Contribution of Small-Airway Abnormalities in Chronic Obstructive Pulmonary Disease Clinical Manifestations: More than a Functional Issue.

2016

Pulmonary and Respiratory Medicinemedicine.medical_specialtybusiness.industryMEDLINESocio-culturalePulmonary diseaseSettore MED/10 - Malattie Dell'Apparato Respiratorio03 medical and health sciencesPulmonary Disease Chronic Obstructive0302 clinical medicineText mining030228 respiratory systemAirway abnormalitiesmedicineHumans030212 general & internal medicineIntensive care medicinebusinessHumanRespiration; international review of thoracic diseases
researchProduct

Corrigendum to: A comparative analysis of Pancoast tumour resection performed via video-assisted thoracic surgery versus standard open approaches (In…

2015

Pulmonary and Respiratory Medicinemedicine.medical_specialtybusiness.industryPancoast tumourSettore MED/21 - Chirurgia ToracicaMEDLINE030204 cardiovascular system & hematologyResectionSurgery03 medical and health sciencesSettore MED/18 - Chirurgia Generale0302 clinical medicineText mining030228 respiratory systemVideo assisted thoracic surgeryMedicineSurgerybusinessCardiology and Cardiovascular Medicine
researchProduct

Obstructive sleep apnea and cancer: a complex relationship

2020

Purpose of review Obstructive sleep apnea (OSA) has been recognized as a risk factor for cancer mainly through hypoxia, based on studies that did not distinguish among cancer types. The purpose of this review is to discuss the most recent data on epidemiology and pathophysiology of the OSA-cancer association. Recent findings According to epidemiological studies, OSA may have different influences on each type of cancer, either increasing or decreasing its incidence and aggressiveness. Time spent with oxygen saturation below 90% appears the polysomnographic variable most strongly associated with unfavorable effects on cancer. Experimental studies support the role of hypoxia as an important ri…

Pulmonary and Respiratory Medicinemedicine.medical_specialtybusiness.industryintermittent hypoxiaexperimental modelsSleep apneaInflammationHypoxia (medical)Bioinformaticsmedicine.diseasemortalityImmune surveillancePathophysiologyNatural historyObstructive sleep apnea03 medical and health sciences0302 clinical medicine030228 respiratory systemEpidemiologyincidencemedicineepidemiology030212 general & internal medicinemedicine.symptombusinessCurrent Opinion in Pulmonary Medicine
researchProduct